Respiratory Updates
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓
Show more📈 Analytical overview of Telegram channel Respiratory Updates
Channel Respiratory Updates (@respiratoryupdates) in the English language segment is an active participant. Currently, the community unites 20 193 subscribers, ranking 1 167 in the Medicine category and 17 219 in the Iran region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 20 193 subscribers.
According to the latest data from 19 October, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 367 over the last 30 days and by 26 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 9.16%. Within the first 24 hours after publication, content typically collects 4.70% reactions from the total number of subscribers.
- Post reach: On average, each post receives 1 849 views. Within the first day, a publication typically gains 948 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
- Thematic interests: Content is focused on key topics such as patient, guideline, edit, reader, society.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁
🟢 Thoracic Research Center🔬
🟢 Tehran University of Medical Sciences🎓”
Thanks to the high frequency of updates (latest data received on 20 October, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Loading data
| Date | Subscriber Growth | Mentions | Channels | |
| 20 October | +14 | |||
| 19 October | +26 | |||
| 18 October | +14 | |||
| 17 October | +12 | |||
| 16 October | +18 | |||
| 15 October | +10 | |||
| 14 October | +18 | |||
| 13 October | +27 | |||
| 12 October | +4 | |||
| 11 October | +6 | |||
| 10 October | +17 | |||
| 09 October | +13 | |||
| 08 October | +13 | |||
| 07 October | +5 | |||
| 06 October | +11 | |||
| 05 October | +16 | |||
| 04 October | +6 | |||
| 03 October | +1 | |||
| 02 October | +12 | |||
| 01 October | +9 |
| 2 | Cardiology Board 2025 مبادرة خير.pdf | 1 996 |
| 3 | No text... | 1 963 |
| 4 | تغییر_گایدلاینها_از_210_تا_2026_1405_06_06.pdf | 4 241 |
| 5 | این کتاب خیلی کاربردیه برای همکاران داخلی | 3 915 |
| 6 | Drug-Induced Diseases | 5 130 |
| 7 | No text... | 4 990 |
| 8 | +1 Staphylococcus aureus Skin and Soft Tissue Infections _ Infect Dis Clin N Am 2026 | 5 101 |
| 9 | No text... | 4 626 |
| 10 | No text... | 3 697 |
| 11 | No text... | 3 096 |
| 12 | No text... | 2 989 |
| 13 | Cystic Fibrosis | 3 879 |
| 14 | Vasopressor weaning in septic shock: Why the field has been asking the wrong question _ Journal of Critical Care Aug26 | 4 856 |
| 15 | +1 🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement | 6 482 |
| 16 | IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf | 5 894 |
| 17 | SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava
Recent updates in advanced pulmonary sarcoidosis
Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295 | 6 299 |
| 18 | Respiratory Medicine
Volume 255, April–May 2026, 108751
Original Research
The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial
https://doi.org/10.1016/j.rmed.2026.108751 | 5 471 |
| 19 | Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z | 4 999 |
| 20 | Review Article
Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials
the Nebulized Heparin Study Group
Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161 | 5 338 |
